NCT02007278View on ClinicalTrials.gov

Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 3, 2014

Primary Completion Date

February 22, 2016

Study Completion Date

February 22, 2016

Conditions
Type 2 DiabetesHypoglycemia
Interventions
DRUG

vildagliptin and metformin (combination)

vildagliptin and metformin combination therapy as 50mg/850mg bid or 50mg/1000mg bid

DRUG

glimepiride

DRUG

Metformin

Trial Locations (8)

1700

Novartis Investigative Site, Manizales

760001

Novartis Investigative Site, Santiago de Cali

11001000

Novartis Investigative Site, Chía

Unknown

Novartis Investigative Site, Medellín

Novartis Investigative Site, Santiago de Cali

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Montería

00000

Novartis Investigative Site, Bogotá

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY